(Q71703391)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

review article

1 reference

title

Modern management of acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

20 October 2019

main subject

1 reference

Reeder GS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Gersh BJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

Current Problems in Cardiology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

585-667

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Angiographic progression of coronary artery disease and the development of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Hemostatic function and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Changing presentation of myocardial infarction with increasing old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effect of infarct location on myocardial salvage assessed by technetium-99m isonitrile

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Tailored thrombolytic therapy. A perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Fibrin-selective thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Coronary angiography after thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Mega-trials and management of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Magnesium in acute MI. Timing is critical

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Timing of Magnesium Therapy Affects Experimental Infarct Size

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Coronary heart disease in residents of Rochester, Minnesota. VI. Hospital and posthospital course of patients with transmural and subendocardial myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Nontransmural myocardial infarction: A comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Hemodynamic Evaluation of Left Ventricular Function in Shock Complicating Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Role of two-dimensional echocardiography in the prediction of in-hospital complications after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Early repair of mechanical complications after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Early repair of ventricular septal rupture after infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Papillary muscle rupture complicating acute myocardial infarction: analysis of 17 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Septal rupture after myocardial infarction: is very early surgery really worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Right ventricular infarction. Clinical and hemodynamic features

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Reversal of atropine-resistant atrioventricular block with intravenous aminophylline in the early phase of inferior wall acute myocardial infarction following treatment with streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Coronary heart disease in women: special considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Influence of age on the relation between heart rate variability, left ventricular ejection fraction, frequency of ventricular extrasystoles, and sudden death after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Ba

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-2806%2896%2980003-X

7 January 2021

10.1016/S0146-2806(96)80003-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8879959%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference